Gengo F M, Manning C
Neuropharmacology Division, Dent Neurologic Institute, Buffalo, NY 14209.
J Allergy Clin Immunol. 1990 Dec;86(6 Pt 2):1034-9. doi: 10.1016/s0091-6749(05)80250-7.
The newer, second-generation H1-receptor antagonists have been shown to have potent antiallergic effects without inducing sleepiness. However, because traditional antihistamines may cause functional or cognitive impairment, the clinician still must consider warning patients about activities that could be hazardous. Because the effects of drugs on driving an automobile are difficult to measure directly, studies must use surrogate activities in a laboratory setting. Effects of antihistamines on the central nervous system are assessed with psychomotor tests, which are selected on the basis of their relativity to real-world activities, to develop a profile of mental processes that may be affected. This article reviews the psychomotor tests and study design used to characterize the intensity and duration of drug effects after single and multiple doses and in combination with other impairing agents such as ethanol. Several studies have been published that assess the effects of cetirizine, an H1-receptor blocker, on mental performance. In the study discussed here, diphenhydramine hydrochloride and hydroxyzine were used as positive controls to demonstrate that the period during which some traditional antihistamines impair performance is different than the period of reported drowsiness they induce. The results of this series of studies show that cetirizine induced minimal changes in mental performance tests and only following the highest (20 mg) dose studied.
新一代第二代H1受体拮抗剂已被证明具有强大的抗过敏作用且不会引起嗜睡。然而,由于传统抗组胺药可能会导致功能或认知损害,临床医生仍必须考虑警告患者关于可能危险的活动。由于药物对驾驶汽车的影响难以直接测量,研究必须在实验室环境中使用替代活动。抗组胺药对中枢神经系统的影响通过精神运动测试来评估,这些测试是根据它们与现实世界活动的相关性来选择的,以建立可能受到影响的心理过程概况。本文回顾了用于表征单次和多次给药后以及与乙醇等其他损害药物联合使用时药物作用强度和持续时间的精神运动测试和研究设计。已经发表了几项评估H1受体阻滞剂西替利嗪对心理表现影响的研究。在本文讨论的研究中,盐酸苯海拉明和羟嗪被用作阳性对照,以证明一些传统抗组胺药损害表现的时间段与它们引起的嗜睡报告时间段不同。这一系列研究的结果表明,西替利嗪仅在研究的最高剂量(20毫克)后才会在心理表现测试中引起最小的变化。